pioglitazone has been researched along with Encephalopathy, Toxic in 3 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, in this population-based cohort study, we investigated the effects of pioglitazone, a PPAR-γ agonist, on the risk of dementia." | 7.85 | Effects of pioglitazone on the incidence of dementia in patients with diabetes. ( Chou, PS; Ho, BL; Yang, YH, 2017) |
| " Therefore, in this population-based cohort study, we investigated the effects of pioglitazone, a PPAR-γ agonist, on the risk of dementia." | 3.85 | Effects of pioglitazone on the incidence of dementia in patients with diabetes. ( Chou, PS; Ho, BL; Yang, YH, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Seydi, E | 1 |
| Servati, T | 1 |
| Samiei, F | 1 |
| Naserzadeh, P | 1 |
| Pourahmad, J | 1 |
| Chou, PS | 1 |
| Ho, BL | 1 |
| Yang, YH | 1 |
| Kalonia, H | 1 |
| Kumar, P | 1 |
| Kumar, A | 1 |
3 other studies available for pioglitazone and Encephalopathy, Toxic
| Article | Year |
|---|---|
Toxicity of Pioglitazone on Mitochondria Isolated from Brain and Heart: An Analysis for Probable Drug-Induced Neurotoxicity and Cardiotoxicity.
Topics: Animals; Brain; Cardiotoxicity; Dose-Response Relationship, Drug; Heart; Hypoglycemic Agents; Male; | 2020 |
Effects of pioglitazone on the incidence of dementia in patients with diabetes.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Dementia; Diabetes Mellitus, Type 2; Dose-Resp | 2017 |
Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
Topics: Animals; Antioxidants; Benzhydryl Compounds; Body Weight; Corpus Striatum; Disease Models, Animal; E | 2010 |